Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous tube feeding and vildagliptin added to insulin for hyperglycemia after acute ischemic stroke
NL-OMON33687Phase 4Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vildagliptin and human insulin in hyperglycemia and stroke (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Mean glucose throughout protocol treatment, Percentage of time spent within target range and 3 more. Planned start Feb 2009; status: not yet recruiting.
02
Drugs
vildagliptinhuman insulin
03
Conditions
hyperglycemiastroke
Beyond the preview
Go deeper on NL-OMON33687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33687.